| Literature DB >> 34885949 |
Mirtha Navarro-Hoyos1, Elizabeth Arnáez-Serrano2, Silvia Quesada-Mora3, Gabriela Azofeifa-Cordero3, Krissia Wilhelm-Romero1, Maria Isabel Quirós-Fallas1, Diego Alvarado-Corella1, Felipe Vargas-Huertas1, Andrés Sánchez-Kopper4.
Abstract
There is increasing interest in research into fruits as sources of secondary metabolites because of their potential bioactivities. In this study, the phenolic profiles of Malus domestica Anna and Jonagold cultivars from Costa Rica were determined by Ultra Performance Liquid Chromatography coupled with High Resolution Mass Spectrometry (HRMS) using a quadrupole-time-of-flight analyzer (UPLC-QTOF-ESI MS), on enriched-phenolic extracts from skins and flesh, obtained through Pressurized Liquid Extraction (PLE). In total, 48 different phenolic compounds were identified in the skin and flesh extracts, comprising 17 flavan-3-ols, 12 flavonoids, 4 chalcones, 1 glycosylated isoprenoid and 14 hydroxycinnamic acids and derivatives. Among extracts, the flesh of Jonagold exhibits a larger number of polyphenols and is especially rich in procyanidin trimers, tetramers and pentamers. Evaluating total phenolic content (TPC) and antioxidant activities using ORAC and DPPH procedures yields higher values for this extract (608.8 mg GAE/g extract; 14.80 mmol TE/g extract and IC50 = 3.96 µg/mL, respectively). In addition, cytotoxicity evaluated against SW620 colon cancer cell lines and AGS gastric cancer cell lines also delivered better effects for Jonagold flesh (IC50 = 62.4 and 60.0 µg/mL, respectively). In addition, a significant negative correlation (p < 0.05) was found between TPC and cytotoxicity values against SW620 and AGS adenocarcinoma (r = -0.908, and -0.902, respectively). Furthermore, a significant negative correlation (p < 0.05) was also found between the number of procyanidins and both antioxidant activities and cytotoxicity towards SW620 (r = -0.978) and AGS (r = -0.894) cell lines. These results align with Jonagold flesh exhibiting the highest abundance in procyanidin oligomers and yielding better cytotoxic and antioxidant results. In sum, our findings suggest the need for further studies on these Costa Rican apple extracts-and particularly on the extracts from Jonagold flesh-to increase the knowledge on their potential benefits for health.Entities:
Keywords: ESI-MS; Malus domestica; UPLC; antioxidant; antitumoral; apple; flavonoids; mass spectrometry; nutraceutic; polyphenols; procyanidins
Mesh:
Substances:
Year: 2021 PMID: 34885949 PMCID: PMC8659030 DOI: 10.3390/molecules26237367
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Total phenolic content from the extracts of M. domestica cultivars.
| Sample | Lyophilization Yield | Extraction Yield | Total Phenolic Content |
|---|---|---|---|
|
| |||
| Skin | 22.95 ± 0.21 | 16.47 ± 0.62 | 472.26 a ± 5.5 |
| Flesh | 15.92 ± 0.45 | 10.69 ± 0.34 | 354.46 b ± 8.4 |
|
| |||
| Skin | 19.94 ± 0.68 | 20.87 ± 0.55 | 417.07 c ± 12.3 |
| Flesh | 14.03 ± 0.53 | 14.18 ± 0.84 | 608.78 d ± 4.4 |
1 g of dry material (DM)/g of fresh weight (FW) expressed as %. 2 Values represent average ± standard deviation (S.D.) from three independent runs for each sample (n = 3). 3 mg of extract/g of dry material. 4 Different superscript letters indicate that differences are significant at p < 0.05 using ANOVA with a Tukey post hoc test.
Figure 1HPLC Chromatograms of M. domestica extracts: (a) Anna skins (b) Anna flesh, in a Phenomenex Luna RP18 C-18 column (150 mm × 4.6 mm × 4 µm) using a Xevo G2-XS QTOF Mass spectrometer (Waters™, Wimslow, UK) in a mass range from 100 to 1500 amu.
Figure 2HPLC Chromatograms of M. domestica extracts: (a) Jonagold skins (b) Jonagold flesh, in a Phenomenex Luna RP18 C-18 column (150 mm × 4.6 mm × 4 µm) using a Xevo G2-XS QTOF Mass spectrometer (Waters™, Wilmslow, UK) in a mass range from 100 to 1500 amu.
Profile of the phenolic compounds identified by UPLC-DAD-ESI-MS/MS in Costa Rican apple cultivars 1.
| No | Tentative Identification | Rt (min) | [M-H]− | Formula | MS2 Fragments | Sample 1 |
|---|---|---|---|---|---|---|
|
| ||||||
|
| Sinapic acid hexoside | 8.91 | 385.1169 | C17H22O10 | [385]: 205, 223 | JF |
|
| Caffeoylquinic acid (I of II) | 10.36 | 353.0871 | C16H17O9 | [353]: 191, 179 | JF |
|
| Caffeoylquinic acid (II of II) | 12.45 | 353.0809 | C16H17O9 | [353]: 191, 180 | JF |
|
| 14.55 | 337.0912 | C16H18O8 | [337]: 173 | AF, JF | |
|
| Shikimic acid | 15.06 | 173.0447 | C7H9O5 | [173]: 93, 111 | AF |
|
| Feruloylquinic acid (I of III) | 15.75 | 367.0983 | C17H20O9 | [367]: 173, 191 | AS, AF |
|
| Feruloylquinic acid (II of III) | 18.62 | 367.1012 | C17H20O9 | [367]: 173, 191 | AS, AF, JS, JF |
|
| Methyl- | 20.82 | 351.1098 | C17H20O9 | [351]: 177 | AS, AF |
|
| Feruloylquinic acid (III of III) | 21.60 | 367.0983 | C17H20O9 | [367]: 173, 191 | AS, AF, JF |
|
| Methyl- | 23.60 | 351.1098 | C17H19O8 | [351]: 177 | AF |
|
| Di- | 28.14 | 571.1675 | C25H31O15 | [571]: 529, 553 | JF |
|
| Di- | 29.88 | 571.1673 | C25H31O15 | [571]: 529, 554 | JS, JF |
|
| Caffeoyl hexoside (I of II) | 31.45 | 341.084 | C15H17O9 | [341]: 161, 179 | AS, AF, JS, JF |
|
| Caffeoyl hexoside (II of II) | 34.65 | 341.084 | C15H17O9 | [341]: 161, 179 | AS, AF, JS |
|
| ||||||
|
| Phloretin-pentosilhexoside (I of II) | 26.14 | 567.1725 | C26H31O14 | [567]: 273 | AS, AF, JS, JF |
|
| Phloretin-pentosilhexoside (II of II) | 26.95 | 567.1725 | C26H31O14 | [567]: 273 | JF |
|
| Phloridzin | 30.00 | 435.1312 | C21H24O10 | [435]: 167, 273 | AS, AF, JS, JF |
|
| Phloretin | 40.98 | 273.0757 | C15H13O5 | [273]: 167, 201 | AS, AF, JS |
|
| ||||||
|
| Quercetin di-hexoside | 19.82 | 625.1378 | C30H25O13 | [625]: 300, 301 | AS, JS, JF |
|
| Quercetin-rutinoside | 22.54 | 609.1459 | C27H29O16 | [609]:300, 301 | AS, JS, JF |
|
| Quercetin-hexoside (I of III) | 23.78 | 463.0878 | C21H19O12 | [463]: 300, 301 | AS, JS, JF |
|
| Quercetin-hexoside (II of III) | 24.95 | 463.0878 | C21H19O12 | [463]: 300, 301 | AS, AF |
|
| Quercetin-pentoside | 25.35 | 433.0732 | C20H17O11 | [433]: 300, 301 | AS, AF, JF |
|
| Quercetin acetyl hexoside | 27.16 | 505.1002 | C23H22O13 | [505]: 300, 301 | AS, JS, JF |
|
| Quercetin-pentosylhexoside | 27.77 | 595.1245 | C26H27O16 | [595]: 300, 301 | JF |
|
| Kaempferol-hexoside | 28.63 | 447.0928 | C21H19O11 | [447]: 284.,285 | AS, AF, JS, JF |
|
| Quercetin pentosyl hexoside | 29.24 | 587.1043 | C25H26O15 | [595]: 300, 301 | JS, JF |
|
| Quercetin-hexoside (III of III) | 31.25 | 463.0834 | C21H20O12 | [463]: 300, 301 | AS, AF, JS, JF |
|
| Kaempferol-hexoside | 36.18 | 477.0944 | C21H20O11 | [447]: 284, 285 | AS, AF, JS |
|
| Quercetin | 37.19 | 301.0353 | C15H10O7 | [301]: 151, 179, 255, 273, 283 | AS, JS |
|
| ||||||
|
| Procyanidin B-type dimer (I of IV) | 5.74 | 577.1292 | C30H25O12 | [577]: 287, 289, 407, 425, 451, 559 | JS, JF |
|
| Procyanidin B-type dimer (II of IV) | 6.12 | 577.1294 | C30H25O12 | [577]: 287, 289, 407, 425, 451, 559 | JF |
|
| Procyanidin B-type dimer (III of IV) | 6.57 | 577.1343 | C30H25O12 | [577]: 287, 289, 407, 425, 451, 559 | AS, AF, JF |
|
| Procyanidin B-type trimer (I of III) | 7.31 | 865.2004 | C45H37O18 | [865]: 287, 289, 575, 577, 695, 713, 739 | JF |
|
| Procyanidin A-type dimer | 7.67 | 591.1147 | C30H24O13 | [575]: 289, 449 | AF, JS |
|
| Procyanidin B-type trimer (II of III) | 8.5 | 865.2004 | C45H37O18 | [865]: 287, 289, 575, 577, 695, 713, 739 | AS, JF |
|
| Catechin | 9.01 | 289.0708 | C15H14O6 | [289]: 205,245, 271 | AS, JF |
|
| Procyanidin B-type dimer (IV of IV) | 9.52 | 577.1392 | C30H25O12 | [577]: 287, 289, 407, 425, 451, 559 | AS, AF, JF |
|
| Procyanidin B-type trimer (III of III) | 11.48 | 865.2004 | C45H37O18 | [865]: 287, 289, 575, 577, 695, 713, 739 | AS, JF |
|
| Procyanidin tetramer B (I of III) | 11.76 | 1153.2629 | C60H49O24 | [1153]: 287, 289, 575, 577, 863, 865, 983, 1001, 1027, 1135 | JF |
|
| Epicatechin | 12.14 | 289.0708 | C15H13O6 | [289]: 205, 245, 271 | AS, JF |
|
| Procyanidin B-type tetramer (II of III) | 12.82 | 1153.2704 | C60H49O24 | [1153]: 287, 289, 575, 577, 863, 865, 983, 1001, 1027, 1135 | JF |
|
| Procyanidin B-type pentamer (I of III) | 16.55 | 1441.2936 | C75H61O30 | [1441]: 287, 289, 575, 577, 865, 1153, 1315 | JF |
|
| Procyanidin B-type pentamer (II of III) | 19.13 | 1441.2939 | C75H61O30 | [1441]: 287, 289, 575, 577, 865, 1153, 1315 | JS, JF |
|
| (epi)catechin 3- | 22.89 | 609.1459 | C27H29O16 | [441]: 153, 289, 315 | JF |
|
| Procyanidin B-type tetramer (III of III) | 23.20 | 1153.2701 | C60H49O24 | [1153]: 287, 289, 575, 577, 863, 865, 983, 1001, 1027, 1135 | AS, JS, JF |
|
| Procyanidin B-type pentamer (III of III) | 32.05 | 1441.2931 | C75H61O30 | [1441]: 287, 289, 575, 577, 865, 1153, 1315 | JF |
|
| ||||||
|
| Vomifoliol-pentosilhexoside | 13.97 | 517.2293 | C24H37O12 | [517]: 205, 385 | AS, JS, JF |
1 Anna skin (AS), Anna flesh (AF), Jonagold skin (JS), Jonagold flesh (JF).
Figure 3Chalcones structure and main fragments.
Figure 4Vomifoliol-pentosylhexoside structure and main fragments.
Figure 5Flavan-3-ols monomers structure and main fragments.
Figure 6(Epi)-Catechin 3-O-gallate structure and main fragments.
Figure 7Procyanidin A-type dimer structure and main fragments.
Figure 8Fragmentation pathways of B-type procyanidin dimers: HRF, Heterocyclic ring fusion; RDA, retro-Diels–Alder; QM, quinone methide.
Figure 9Proanthocyanidin B-type trimers, tetramers and pentamers structures and main fragments.
Figure 10Kaempferol hexoside fragmentation.
Figure 11Quercetin fragmentation pathway.
Figure 12Flavonol glycosides structure and main fragments.
Figure 13Shikimic acid structure and main fragments.
Figure 14Structures and main fragments of coumaroyl and caffeic acid derivatives.
Figure 15Caffeoylquinic acid fragmentation pathway.
Figure 16Structure and fragmentation of glycosylated and acetyl-glycosylated derivatives from hydroxycinnamic acids.
Figure 17Structures and main fragments of sinapic acid and feruloyl quinic acid derivatives.
DPPH and ORAC antioxidant activity from the extracts of M. domestica cultivars.
| Sample | DPPH 1,2 | ORAC 1.2 | |
|---|---|---|---|
| IC50 (μg Extract/mL) | (mmol TE/g Extract) | (mmol TE/g Extract) | |
|
| |||
| Skin | 6.90 a ± 0.02 | 3.25 a ± 0.01 | 11.19 a ± 0.25 |
| Flesh | 11.33 b ± 0.05 | 1.98 b ± 0.01 | 5.96 b ± 0.23 |
|
| |||
| Skin | 9.76 c ± 0.17 | 2.30 c ± 0.04 | 7.44 c ± 0.10 |
| Flesh | 3.96 d ± 0.02 | 5.68 d ± 0.03 | 14.80 d ± 0.26 |
1 Values are expressed as mean ± S.D. 2 Different superscript letters in the same column indicate that differences are significant at p < 0.05 using ANOVA with a Tukey post hoc as statistical test. ORAC, oxygen radical absorbance capacity; DPPH, 2,2-diphenyl-1-picrylhidrazyl method.
Cytotoxicity of M. domestica extracts to gastric (AGS) and colon (SW-620) carcinoma cells as well as to Vero non-tumoral cells.
| Sample | IC50 (µg/mL) 1,2 (SI) 3 | ||
|---|---|---|---|
| AGS | SW-620 | Vero | |
|
| |||
| Skin | 167.22 a,* ± 10 (3.0) | 295.93 b,# ± 29 (1.7) | > 500 a,≠ |
| Flesh | > 500 b,* | > 500 a,* | > 500 a,* |
|
| |||
| Skin | 398.44 c,* ± 7 (1.3) | > 500 a,* | 305.72.b,* ± 30 |
| Flesh | 60.03 d,* ± 1.7 (5.1) | 62.41 c,* ± 5.2 (4.9) | > 500 a,# |
1 Different superscript letter in the same column indicates that differences are significant at p < 0.05 using ANOVA with a Tukey post hoc as statistical test. 2 Different superscript signs in the same row indicate that differences are significant at p < 0.05 using ANOVA with a Tukey post hoc as statistical test. 3 Selectivity Index.
Figure 18Cytotoxicity dose–response curves of apple extracts on AGS and SW620 tumor cell lines. Results are presented as mean ± SE of three independent experiments. (a) Samples in AGS cells (b) Samples in SW620 cells.